Koers Quick-Med Technologies, Inc. Other OTC
Aandelen
QMDT
US74837Q1067
Biotechnologie & Medisch Onderzoek
Omzet 2012 | 997K 933K | Omzet 2013 | 928K 868K | Marktkapitalisatie | 2,28 mln. 2,13 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2012 | -1 mln. -935K | Nettowinst (verlies) 2013 | - 0 | EV/omzet 2012 | 10,8 x |
Nettoschuld 2012 | 7,43 mln. 6,95 mln. | Nettoschuld 2013 | 7,86 mln. 7,35 mln. | EV/omzet 2013 | 10,9 x |
K/w-verhouding 2012 |
-1,99
x | K/w-verhouding 2013 |
-3,19
x | Werknemers | - |
Dividendrendement 2012 * |
-
| Dividendrendement 2013 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bernd Liesenfeld
PSD | President | 53 | 01-01-04 |
William Toreki
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-02 |
Gregory Schultz
BRD | Director/Board Member | 73 | 01-07-00 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gerald Olderman
BRD | Director/Board Member | 90 | 01-07-97 |
Gregory Schultz
BRD | Director/Board Member | 73 | 01-07-00 |
Dale Bergman
BRD | Director/Board Member | 67 | 28-02-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |